Fish & Richardson is one of the most active firms handling post-grant matters, and in 2012, kicked-off a webinar series designed to share practice tips, nuances, observations, and strategy. Recordings for previous webinars in this series are included below, with the most recent appearing first.
Fish principals John Dragseth and Craig Countryman have over 60 Supreme Court and Federal Circuit appeals between them, and are watching the coming tsunami of PTAB appeals with great interest. To that end, they have tracked interesting cases working their way through the PTAB and explained them in this presentation while analyzing what effect those cases may have on future PTAB and litigation practice.
PTAB proceedings almost always involve concurrent litigation. The interplay between PTAB proceedings and district court litigation can be complex, and various strategic objectives can be achieved through a PTAB challenge. In this session we discussed how timing of a PTAB proceeding impacts concurrent litigation.
In keeping with our goal of discussing topics of interest to practitioners, this month we discussed recent developments related to prosecution bars and CBM proceedings. We also explored the PTAB’s treatment of motions to exclude evidence.
The PTAB recently issued several decisions of interest to practitioners. These decisions relate to a number of diverse topics, including claim amendments, live testimony during the oral hearing, and the use of terminal disclaimers to avoid the broadest reasonable interpretation standard. Join us as we discuss these decisions and their strategic implications.
The PTAB recently conducted a series of road shows throughout the country. The judges shared statistics and insights, and practitioners provided input. Fish’s Post-Grant Practice co-chairs participated in two of these road shows. In this webinar they shared their thoughts, takeaways, and practice tips from the road shows. In addition, they discussed recent noteworthy developments in CBM and IPR practice.
IPR and CBM petitions present unique opportunities and issues in the biopharma area for both branded and generic companies. The number of petitions being filed in this area is growing steadily. Listen in as we explored strategic issues related to post-grant practice, Hatch-Waxman litigation, and biosimilars.
In this session, heard how changes in district court litigation due to PTAB proceedings have impacted our audience of practitioners. We shared experiences and lessons learned by those attending the webinar, and enabled attendees to pose questions and provide comments during the session. Talking points included:
In our March webinar, we continued our examination of CBM practice, including CBM eligibility, and reviewability of PTAB decisions related to the same. The webinar covered the definition of covered business method patent under the AIA, as construed by the PTAB, including the exclusion of “patents for technological inventions” and the requirement that, to be eligible for CBM review, the target patent must claim activities that are “financial in nature, incidental to a financial activity or complementary to a financial activity.” We also discussed recent noteworthy developments relating to stays and final written decisions.
In this webinar, the co-chairs of Fish & Richardson’s post-grant practice considered two topics of interest to practitioners: joinder of multiple proceedings and CBM eligibility. The discussion included a review of significant PTAB rulings, including the PTAB’s recently issued final written decision in Liberty Mutual v. Progressive Casualty, as well as practice tips and pointers.
In this webinar, the co-chairs of Fish & Richardson’s post-grant practice discussed significant developments in IPR practice that took place during 2013. They addressed questions such as: What have we learned about this tool? What can we expect going forward?
The discussion included a review of significant PTAB rulings, as well as practice tips and pointers.
Fill out the form below to receive our monthly newsletter and updates on your selected areas of interest. You can unsubscribe at any time by clicking the unsubscribe link at the bottom of the email.
